467 related articles for article (PubMed ID: 17898050)
21. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
22. Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus.
Karimi L; Crawford DH; Speck S; Nicholson LJ
J Gen Virol; 1995 Apr; 76 ( Pt 4)():759-65. PubMed ID: 9049321
[TBL] [Abstract][Full Text] [Related]
23. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
Ellis AL; Wang Z; Yu X; Mertz JE
J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member.
Liu S; Liu P; Borras A; Chatila T; Speck SH
EMBO J; 1997 Jan; 16(1):143-53. PubMed ID: 9009275
[TBL] [Abstract][Full Text] [Related]
25. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
[TBL] [Abstract][Full Text] [Related]
26. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
27. Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.
Wu H; Li T; Zeng M; Peng T
Cell Microbiol; 2012 Apr; 14(4):546-59. PubMed ID: 22188237
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
[TBL] [Abstract][Full Text] [Related]
29. Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent.
Segouffin C; Gruffat H; Sergeant A
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1529-36. PubMed ID: 8757996
[TBL] [Abstract][Full Text] [Related]
30. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines.
Cen H; McKnight JL
Virus Res; 1994 Jan; 31(1):89-107. PubMed ID: 8165871
[TBL] [Abstract][Full Text] [Related]
31. Identification of ERdj3 and OBF-1/BOB-1/OCA-B as direct targets of XBP-1 during plasma cell differentiation.
Shen Y; Hendershot LM
J Immunol; 2007 Sep; 179(5):2969-78. PubMed ID: 17709512
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
33. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
Bhende PM; Seaman WT; Delecluse HJ; Kenney SC
J Virol; 2005 Jun; 79(12):7338-48. PubMed ID: 15919888
[TBL] [Abstract][Full Text] [Related]
34. Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.
Quinlivan EB; Holley-Guthrie EA; Norris M; Gutsch D; Bachenheimer SL; Kenney SC
Nucleic Acids Res; 1993 Jul; 21(14):1999-2007. PubMed ID: 8393562
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.
Ruf IK; Rawlins DR
J Virol; 1995 Dec; 69(12):7648-57. PubMed ID: 7494273
[TBL] [Abstract][Full Text] [Related]
36. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
37. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
Schepers A; Pich D; Hammerschmidt W
Virology; 1996 Jun; 220(2):367-76. PubMed ID: 8661388
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
Daibata M; Speck SH; Mulder C; Sairenji T
Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
[TBL] [Abstract][Full Text] [Related]
40. TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.
Murata T; Sato Y; Nakayama S; Kudoh A; Iwahori S; Isomura H; Tajima M; Hishiki T; Ohshima T; Hijikata M; Shimotohno K; Tsurumi T
J Biol Chem; 2009 Mar; 284(12):8033-41. PubMed ID: 19164291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
